A directed screen using previously described factors known to give rise to mesoderm tissue were used to determine medium compositions that give rise to FOXF1+ mesoderm. BMP4 in combination with CHIR99021 (CHIR, 1.5 µM) resulted in increased expression of FOXF1, whereas Activin A (ACT-A) or VEGFA (VEGF) with CHIR had no response. Further combinations of BMP4 with ACT-A and VEGF demonstrated that BMP4 and VEGF in combination with CHIR lead to the highest expression of FOXF1. Data are expressed as mean ± SD of 3 replicates shown. (D) Increasing the concentration of CHIR to 5µM in combination with BMP4 and VEGF in an independent assay caused a decrease in the expression of FOXF1. Data are expressed as mean ± SD of 3 replicates shown. (E) 1.5 µM CHIR in combination with VEGF and BMP4 lead to a significant increase in FOXF1 protein compared to StemDiff mesoderm induction medium (MIM). While 5µM CHIR (+ BMP4 + VEGF) lead to similar levels of FOXF1 protein compared to Stemdiff MIM, this concentration of CHIR also induced expression of PDGFRα, a marker of paraxial mesoderm. Inhibition with the TGFβ inhibitor SB431542 (SB) blocked protein expression of FOXF1 and increased expression of the somatic marker IRX3.(F) Transcription of the somatic mesoderm marker IRX3 was low or absent from mesoderm produced by in house or StemDiff mesoderm induction mediums, however, additional inhibition with SB431542 induced transcription of the somatic mesoderm marker IRX3 and inhibited FOXF1 protein expression (Fig S1E) . Data are expressed as mean ± SD of 3 replicates shown.
(G) Model showing that the presence or absence TGFβ signaling can specify either splanchinic or somatic mesoderm subcompartments, respectively. 6. Add 500 μl of ACF enzymatic inhibition solution to each well of a 6 well plate.
7. Further suspend cells in 2 ml of cell wash buffer and gently remove cells from the plate by washing with a pipette. Check that most cells have been dislodged from the plate surface with a light microscope. If not, rewash with more cell wash buffer as needed.
Methods S1 cont. 8. Transfer cell suspension to an appropriate tube and centrifuge at 300 g for 5 minutes. Check for the appearance of a cell pellet at the bottom of the tube.
9. Remove the supernatant and resuspend pelleted cells in an appropriate amount of MesenCult-ACF Plus medium (4 ml per each well passaged). Cells will be passaged 1:2.
10. Prior to cell plating, aspirate MesenCult-ACF attachment substrate in PBS without calcium or magnesium from wells. Wash once with PBS and add cells suspended in MesenCult-ACF Plus medium (2 ml each well) to wells coated with MesenCult-ACF attachment substrate. Agitate plate to spread cells evenly on well surface and incubate plate at 37°C in a 5% CO2 incubator undisturbed.
11. Change 100% of the culture medium daily. After reaching 90% confluence, continue to passage cells 1:2 for further expansion until they are >95% positive for CD105, CD73, CD90, CD146, and PDGFRβ cell surface markers as determined by flow cytometry. This usually occurs between 20 and 30 days. After full maturation of the MSC phenotype as determined by flow cytometry, cells can be passaged at lower densities (1:4-1:6 split). After their maturation, cells should be split when the high-density regions in the wells reach approximately 80% confluence. Growing MSCs to higher densities results in decreased differentiation potential over time. Methods S1 cont.
Note: EGM-2 medium can be replaced with DMEM containing 10% FBS for both beige induction and beige maintenance medium. It is often better to use DMEM containing 10% FBS when comparing iPSC-derived beige cells directly to primary cells, since primary cells will not differentiate properly in EGM2 medium.
